Functional Lung Avoidance Planning Guided by Lung Perfusion PET/CT Versus Anatomical Planning for Lung Stereotactic Body Radiotherapy
NCT07289646 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 418
Last updated 2026-01-14
Summary
Stereotactic body radiotherapy (SBRT) has an increasing role in the treatment of both primary and secondary lung tumors. However, lung SBRT remains associated with significant radiation induced lung injury (RILI). Indeed, the reported incidence of symptomatic radiation induced lung injury (grade≥2) in the published literature is up to 20%. A current challenge of lung SBRT is therefore to better preserve lung function and to reduce pulmonary toxicity.
During standard lung SBRT planning, dose constraints are defined on the anatomical lung volume. This planning considers the lung as functionally uniform and does not take into account the variability of regional lung function distribution. Functional lung avoidance is an emerging concept in lung radiotherapy (RT). The technique aims at personalizing RT treatment planning to individuals' lung functional distribution, by sparing functional pulmonary areas while prioritizing delivery of high doses to non-functional regions.
68Ga-MAA lung perfusion PET/CT is a novel imaging modality for regional lung function assessment. As compared with conventional lung scintigraphy, lung perfusion PET/CT is inherently a vastly superior technology for image acquisition (higher sensitivity and spatial resolution, greater access to respiratory gated acquisition). A more accurate lung functional mapping improves the possibility of functional lung avoidance planning for SBRT.
The hypothesis is that functional lung avoidance planning guided by 68Ga-MAA perfusion PET/CT, while delivering an optimal dose to the tumor, will reduce the frequency of RILI in patients treated with lung SBRT.
Conditions
- Stereotactic Body Radiotherapy
- 68Ga-MAA
- Lung Cancer (Diagnosis)
Interventions
- RADIATION
-
Conventional anatomical planning radiotherapy
Conventional anatomical planning will be performed
- RADIATION
-
Functional Lung avoidance planning
Functional Lung Avoidance guided by lung perfusion PET/CT imaging
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-15
- Primary Completion
- 2029-01-31
- Completion
- 2029-05-15
Countries
- France
Study Locations
More Related Trials
-
Stereotactic Body Radio Therapy (SBRT) for Early-stage Non Small Cell Lung Cancer (NSCLC)
NCT00870116 ·Status: UNKNOWN ·Phase: NA
-
Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver Tumors
NCT04242342 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Follow-up of Pulmonary Radiotoxicity for Bronchopulmonary Cancer.
NCT03931356 ·Status: COMPLETED
-
Radiation Pneumonitis After SBRT for NSCLC
NCT02428049 ·Status: ACTIVE_NOT_RECRUITING
-
Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension
NCT03029416 ·Status: WITHDRAWN ·Phase: PHASE2
-
Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer
NCT05802654 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Functional Imaging of Treatment Effects: A Companion Protocol to a Study of Extracranial Stereotactic Radioablation in Early Stage Non-Small Cell Lung Cancer
NCT00246116 ·Status: COMPLETED ·Phase: NA
-
Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System
NCT02224547 ·Status: UNKNOWN ·Phase: PHASE2
-
LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC
NCT01795521 ·Status: UNKNOWN ·Phase: PHASE2
-
Stereotactic Body Radiation Therapy (SBRT) for Lung Tumors
NCT00632281 ·Status: COMPLETED ·Phase: NA
-
Study of the Decrease of Length of Stereotactic Body Radiation Therapy in Lung Cancer
NCT03921957 ·Status: UNKNOWN ·Phase: NA
-
Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer
NCT07259447 ·Status: RECRUITING ·Phase: NA
-
Prevention of Locally Advanced NSCLC Radiotherapy Pneumonia by Inhaling Beclomethasone Propionate
NCT03886441 ·Status: UNKNOWN ·Phase: PHASE2
-
Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
NCT00750269 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Locally Invasive NSCLC Treated With NEo-Adjuvant Stereotactic Body RadioTherapy and REsection
NCT02433574 ·Status: UNKNOWN ·Phase: NA
-
A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC
NCT02314364 ·Status: COMPLETED ·Phase: PHASE2
-
An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System
NCT02067858 ·Status: TERMINATED ·Phase: NA
-
Prognosis of Inpatients Evaluated for Palliative Radiotherapy
NCT02312791 ·Status: COMPLETED
-
PembRolIzuMab and Stereotactic Body Radiotherapy In Metastatic Non-small-cell lunG Cancer Patients
NCT03436056 ·Status: TERMINATED ·Phase: PHASE1
-
Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer
NCT02975609 ·Status: UNKNOWN ·Phase: PHASE2
-
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery
NCT00551369 ·Status: COMPLETED ·Phase: PHASE2
-
Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.
NCT02862288 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC
NCT00246181 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With Chemoradiation
NCT01580579 ·Status: COMPLETED
-
Stereotactic Body Radiotherapy Followed by Surgical Stabilization for Patients With Unstable Spinal Metastases
NCT02622841 ·Status: COMPLETED ·Phase: PHASE1/PHASE2